Location History:
- Herisau, CH (2005)
- Winterthur, CH (2006 - 2007)
Company Filing History:
Years Active: 2005-2007
Title: Innovations and Contributions of Lars Nieba
Introduction
Lars Nieba is a notable inventor based in Winterthur, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of novel methods for vaccine production and gene expression regulation. With a total of three patents to his name, Nieba's work has the potential to impact the treatment of infectious diseases, allergies, and cancers.
Latest Patents
One of Lars Nieba's latest patents is titled "Ordered molecular presentation of antigens, method of preparation and use." This invention provides compositions and processes for producing ordered and repetitive antigen arrays. These compositions are particularly useful for creating vaccines aimed at preventing infectious diseases, treating allergies, and addressing cancers. The technology includes a versatile cassette-type system known as AlphaVaccine Technology, which facilitates the production of antigen-coated viral particles. Another significant patent is the "Inducible alphaviral gene expression system." This invention introduces novel expression vectors that allow for tight regulation of gene expression in eukaryotic cells. The vectors comprise nucleotide sequences that are transcribed into RNA molecules, which are then replicated by a temperature-sensitive replicase. This innovation opens new avenues for producing heterologous proteins and untranslated RNA molecules, along with pharmaceutical compositions for administration.
Career Highlights
Lars Nieba is currently associated with Cytos Biotechnology AG, a company focused on developing innovative therapeutic solutions. His work at Cytos has been instrumental in advancing the understanding and application of antigen presentation and gene expression technologies.
Collaborations
Nieba has collaborated with notable colleagues such as Wolfgang Andreas Renner and Martin F. Bachmann. Their combined expertise has contributed to the successful development of groundbreaking technologies in the field of biotechnology.
Conclusion
Lars Nieba's innovative patents and contributions to biotechnology highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in vaccine development and gene expression regulation.